MethylGene Inc.
MethylGene is a biopharmaceutical company focused on the discovery, development and commercialization of novel and proprietary enzyme inhibitors for the treatment of cancer and infectious diseases.
Investment year: 2005
Industry sector: Biotechnology
Region: Quebec
Fund:
Diversified Portfolio
Follow MethylGene Inc.
BDC Venture Capital Partner
